What are Utah Medical Products's profit margins?

Utah Medical Products (UTMD) runs a 57.9% gross margin and a 28.8% operating margin, with a 28.9% net margin.

Where do Utah Medical Products's ratios come from?

Every ratio is computed from Utah Medical Products's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Utah Medical Products UTMD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	57.1%-1.9pp	59%-0.8pp	59.8%-1.8pp	61.6%-1.4pp
Operating margin	29.6%-3.6pp	33.2%-0.2pp	33.4%-4.4pp	37.9%-0.6pp
Net margin	29.3%-4.6pp	33.9%+0.8pp	33.1%+1.6pp	31.5%+1.4pp
EBITDA margin	37.3%-2.8pp	40.1%-5.9pp	46%-5.3pp	51.3%-2.0pp
Free cash flow margin	37.2%+1.5pp	35.7%-7.4pp	43.1%+4.2pp	38.9%-3.2pp
Returns
Return on equity	9.5%-1.8pp	11.3%-2.4pp	13.7%-1.2pp	14.9%+0.8pp
Return on assets	9.2%-1.5pp	10.8%-2.1pp	12.8%-0.9pp	13.8%+0.7pp
Return on invested capital	26.5%-5.3pp	31.8%-4.9pp	36.7%+0.1pp	36.6%+6.8pp
Efficiency
Asset turnover	0.3×0.0×	0.3×-0.1×	0.4×0.0×	0.4×0.0×
Inventory turnover	2×+0.2×	1.8×-0.4×	2.2×-0.4×	2.6×-0.2×
Liquidity
Current ratio	37.6×+12.0×	25.6×+3.1×	22.6×+7.5×	15.1×-4.4×
Quick ratio	34.6×+11.3×	23.3×+2.8×	20.5×+6.9×	13.6×-4.2×
Cash ratio	33×+10.9×	22.1×+2.4×	19.7×+7.1×	12.6×-3.7×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-6×-0.9×	-5×-1.0×	-4×-1.2×	-2.8×-0.5×
Per Share
Book value per share	$36.81+9.8%	$33.52-5.0%	$35.28+12.5%	$31.36+7.1%
Valuation
Market capitalization	$219.63M+26.4%	$208.48M-31.8%	$305.63M-16.2%	$364.68M-0.1%
Enterprise value	$132.44M+42.5%	$126.07M-40.8%	$213.11M-26.5%	$290.02M-4.8%
Price / earnings	20.3×+6.4×	15×-3.3×	18.4×-3.8×	22.1×-2.6×
Price / sales	5.9×+1.4×	5.1×-1.0×	6.1×-0.9×	7×-0.5×
Price / book	1.9×+0.4×	1.8×-0.6×	2.4×-0.8×	3.2×-0.2×
EV / EBITDA	10.5×+4.0×	7.7×-1.5×	9.2×-1.6×	10.8×-0.8×
EV / sales	3.9×+1.2×	3.1×-1.2×	4.2×-1.3×	5.5×-0.7×
Free cash flow yield	5.6%-1.9pp	7%-0.1pp	7.1%+1.5pp	5.6%-0.1pp
Earnings yield	4.7%-2.2pp	6.7%+1.2pp	5.4%+0.9pp	4.5%+0.5pp
Dividend yield	1.7%-0.5pp	2%+0.6pp	1.4%+0.5pp	0.9%-2.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Utah Medical Products.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Utah Medical Products's profit margins?: Utah Medical Products (UTMD) runs a 57.9% gross margin and a 28.8% operating margin, with a 28.9% net margin.
Where do Utah Medical Products's ratios come from?: Every ratio is computed from Utah Medical Products's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.